Hoth Therapeutics And Algorithm Sciences Terminate Letter Of Intent To Merge

Hoth to Concentrate on its Current Pipeline and Continue Phase 2 Clinical Study Hoth Has Over Twelve Months Cash on Balance Sheet

Hoth to Concentrate on its Current Pipeline and Continue Phase 2 Clinical Study

Hoth Has Over Twelve Months Cash on Balance Sheet

NEW YORK, May 12, 2023 /PRNewswire/ — Hoth Therapeutics, Inc. (NASDAQ:HOTH), a patient focused biopharmaceutical company, today announced that they have entered into a mutual agreement with Algorithm Sciences, Inc. (“Algorithm”) to terminate their previously announced decision to merge, originally announced on April 26, 2023.

After further discussions and review, both Hoth and Algorithm have determined that a definitive merger agreement cannot be reached and it is in the best interest of both companies to terminate the letter of intent and continue to operate as separate companies.

“Hoth is continuing development from a position of strength and stability with over $12M on the balance sheet to carry us through more than twelve months of continued development,” stated Robb Knie, CEO of Hoth. “Our Phase 2a study for patients suffering from the side effects of EGFRi treatment is underway and we believe HT-001 to be a groundbreaking treatment. I look forward to updating our shareholders as further developments of our therapeutics become available.”

Total
0
Shares
Related Posts
Read More

Here’s Where To Buy Legal Weed While Getting A Tattoo And A Beer: New Cannabis Stores In US And More

These days, smaller players in the alcohol industry are opting to venture into cannabis. As highlighted in a recent story by Green Market Report's John Schroyer,  Beer World located in Greene County, upstate New York, is eyeing an opportunity to take over a legal dispensary permit. The beer distributor intends to set up a cannabis shop in a building where its beer store is located. According to the Times Union, stores won't be sharing the same entrance though, and will be run separately. In the meantime, cannabis sales in North America seem to be thriving, if we factor in the number of new stores that are kicking off sales.

BUD